EUVIMEDEUVIMED entdecken
Crossref

Molecular Crosstalk by miR-449a and miR-34b in endometrial and ovarian cancer cells in vitro

Anuradha Sharma, Hanisha, Akanksha Rana, Indu Sharma

Gene · 2025

DOI: 10.1016/j.gene.2025.149337 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gene, 2025. Verfasst von Anuradha Sharma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Zoology, Panjab University, Chandigarh 160014, INDIA. Electronic address: anuradhasharma1401@gmail.com. Hauptthemen laut MEDLINE: MicroRNAs, Endometrial Neoplasms, Ovarian Neoplasms. Die Arbeit nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: Endometrial and ovarian cancers, the sixth and eighth most prevalent cancers in women globally, account for nearly 8% of all new female cancer cases annually. MicroRNAs (miRNAs) have emerged as a promising field in cancer treatment, offering new avenues for targeted therapies and diagnostic tools. Recent miRNA-based cancer research has uncovered various miRNAs commonly dysregulated in cancer and which possess tumor-suppressive functions. These miRNAs influence genes crucial for cellular differentiation, proliferation, apoptosis, and metabolism. MAIN METHODS: In the present study, the researchers investigated the effect of dysregulation of two such miRNAs, miR-449a and miR-34b, on the oncogenes involved in the progression of endometrial and ovarian cancer using the respective RL95-2 and SKOV3 cell lines. The transcriptional gene expression analysis was done by Real-Time Quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR). KEY FINDINGS: It was found that the overexpression of miR-449a and miR-34b downregulated HIF-1α, VEGF, c-Myc, COX-2, and TNF-α while upregulating TP53 in both cancer types. Conversely, inhibiting these miRNAs increased the levels of HIF-1α, VEGF, c-Myc, COX-2, and TNF-α, and decreased TP53. However, co-transfection with both mimic and inhibitor had varying effects. SIGNIFICANCE: The study demonstrated that these miRNAs could influence critical processes such as angiogenesis, proliferation, inflammation, tumorigenesis, and apoptosis in cancer cells, highlighting their potential as therapeutic targets. However, the varied effects observed with the co-transfection of mimics and inhibitors suggest a complex interplay that requires further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsEndometrial NeoplasmsOvarian NeoplasmsHumansFemaleGene Expression Regulation, NeoplasticCell Line, TumorCell ProliferationApoptosisVascular Endothelial Growth Factor AHypoxia-Inducible Factor 1, alpha SubunitCyclooxygenase 2Tumor Suppressor Protein p53

Stichwörter der Autor:innen

Endometrial cancerOncogenesOvarian cancerTransfectionmiR-34bmiR-449a

Substanzen

MicroRNAsMIRN34 microRNA, humanMIRN449 microRNA, humanVascular Endothelial Growth Factor AHypoxia-Inducible Factor 1, alpha SubunitCyclooxygenase 2HIF1A protein, humanTumor Suppressor Protein p53

Autor:innen und Institutionen

  • Department of Zoology, Panjab University, Chandigarh 160014, INDIA. Electronic address: anuradhasharma1401@gmail.com.
  • Department of Zoology, Panjab University, Chandigarh 160014, INDIA. Electronic address: hanishamehta21@gmail.com.
  • Department of Zoology, Panjab University, Chandigarh 160014, INDIA. Electronic address: akanksharana30@gmail.com.
  • Department of Zoology, Panjab University, Chandigarh 160014, INDIA. Electronic address: indu2702@pu.ac.in.

Zitieren

APA

Sharma, A., Hanisha, Rana, A., & Sharma, I. (2025). Molecular Crosstalk by miR-449a and miR-34b in endometrial and ovarian cancer cells in vitro. Gene. https://doi.org/10.1016/j.gene.2025.149337

Vancouver

Sharma A, Hanisha, Rana A, Sharma I. Molecular Crosstalk by miR-449a and miR-34b in endometrial and ovarian cancer cells in vitro. Gene. 2025. doi:10.1016/j.gene.2025.149337

BibTeX
@article{Sharma2025,
  author = {Sharma, Anuradha and Hanisha and Rana, Akanksha and Sharma, Indu},
  title = {Molecular Crosstalk by miR-449a and miR-34b in endometrial and ovarian cancer cells in vitro},
  journal = {Gene},
  year = {2025},
  doi = {10.1016/j.gene.2025.149337}
}
Kostenlos starten →